Skip Content
 
Page Banner Image

HSC National Symposium

The National Symposium is an opportunity to gather with the local HD community in your area and learn about the latest in Huntington disease research every two years. The 2017 National Symposium was held on October 14th at 18 volunteer-led locations across Canada, with over 500 people registered to network, and learn from our expert presenters about the latest in HD research.

Presentation One: The Silver Lining: Learning from Unsuccessful HD Clinical Trials

Dr. Tamara Maiuri from McMaster University, shared results of recent HD Clinical trials including Amaryllis, OpenHeart, Premordien and Pride to help us understand why these trials were stopped, but more importantly, what researchers learned that will continue to guide us in the future for treatments of Huntington disease.

Click here for a summary of Dr. Maiuri’s presentation. 

 

Presentation Two: What’s Next? Clinical Trials in HD throughout Canada

Our panel of researchers, including Dr. Mark Guttman from Centre for Movement Disorders, Toronto, Dr. Blair Leavitt from the University of British Columbia, and Dr. Oksana Suchowersky of the University of Alberta each shared the latest news on their research and upcoming clinical trials, including HD-Clarity, Huntingtin Lowering, and GM-1. Moderated by HSC CEO Bev Heim-Myers, this presentation is sure to lead you to Believe!

Click here for a summary of Dr. Guttman, Dr. Leavitt and Dr. Suchowersky’s presentation.

 

 

Thank you to our volunteers, presenters, and staff for all of your efforts in putting together the National Symposium! Stay tuned for details about the 2019 HSC National Symposium!

 


We support those facing huntington disease
 Latest Blog
 Questions

Questions

Let Us Know How We Can Help
Enter your name, email address and question(s) below for assistance.

 Connect
 Newsletter

Newsletter

Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up